December 2025CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical systemRegulatory clearance of CMR’s most advanced ...

As competition intensifies among surgical robot makers, CMR said its soft tissue platforms are the second most used systems ...

CMR Surgical announced today that its second-generation surgical robot, Versius Plus, received FDA 510(k) clearance.

CMR Surgical’s Versius Plus robot’s clearance follows the FDA’s de novo classification of the company’s first-generation ...

The FDA previously granted marketing authorization for CMR’s first-generation Versius Surgical System in October 2024.

Medtronic and CMR Surgical got the FDA’s green light this month, while SS Innovations applied for clearance. Catch up on the ...

CMR Surgical said it is on track to begin commercialization of its Versius Plus surgical robotic platform in 2026 in the United States.

Globally, Versius is the second most utilized surgical robotic system, withover26,000 surgical procedures completed across Europe, Latin America, Asia, Middle East and Africa With its unique compact ...

CMR Surgical has received FDA clearance for its Versius Plus surgical robotic platform. The clearance covers cholecystectomy ...

“Built on years of global clinical use data, Versius Plus delivers the flexibility and intelligence today’s healthcare ...